|
Pronunciation |
|
(pen
i SIL in jee PROE
kane) |
|
|
U.S. Brand
Names |
|
Crysticillin® A.S.;
Wycillin® |
|
|
Generic
Available |
|
Yes |
|
|
Canadian Brand
Names |
|
Ayercillin® |
|
|
Synonyms |
|
APPG; Aqueous Procaine Penicillin G; Procaine Benzylpenicillin; Procaine
Penicillin G |
|
|
Pharmacological Index |
|
Antibiotic, Penicillin |
|
|
Use |
|
Moderately severe infections due to Treponema pallidum and other
penicillin G-sensitive microorganisms that are susceptible to low but prolonged
serum penicillin concentrations |
|
|
Pregnancy Risk
Factor |
|
B |
|
|
Contraindications |
|
Known hypersensitivity to penicillin or any component; also contraindicated
in patients hypersensitive to procaine |
|
|
Warnings/Precautions |
|
May need to modify dosage in patients with severe renal impairment, seizure
disorders, or history of hypersensitivity to cephalosporins; avoid I.V.,
intravascular, or intra-arterial administration of penicillin G procaine since
severe and/or permanent neurovascular damage may occur |
|
|
Adverse
Reactions |
|
>10%: Local: Pain at injection site
<1%: Myocardial depression, vasodilation, conduction disturbances, CNS
stimulation, seizures, confusion, drowsiness, hemolytic anemia, positive Coombs'
reaction, sterile abscess at injection site, myoclonus, interstitial nephritis,
pseudoanaphylactic reactions, Jarisch-Herxheimer reaction, hypersensitivity
reactions |
|
|
Overdosage/Toxicology |
|
Symptoms of penicillin overdose include neuromuscular hypersensitivity
(agitation, hallucinations, asterixis, encephalopathy, confusion, and seizures)
and electrolyte imbalance with potassium or sodium salts, especially in renal
failure
Hemodialysis may be helpful to aid in the removal of the drug from the blood,
otherwise most treatment is supportive or symptom directed |
|
|
Drug
Interactions |
|
Decreased effect: Tetracyclines may decrease penicillin effectiveness;
decreased oral contraceptive effect is possible
Increased effect:
Probenecid may increase penicillin levels
Aminoglycosides may result in synergistic efficacy; heparin and parenteral
penicillins may result in increased bleeding |
|
|
Stability |
|
Store in refrigerator |
|
|
Mechanism of
Action |
|
Inhibits bacterial cell wall synthesis by binding to one or more of the
penicillin binding proteins (PBPs); which in turn inhibits the final
transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus
inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing
activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while
cell wall assembly is arrested. |
|
|
Pharmacodynamics/Kinetics |
|
Absorption: I.M.: Slowly absorbed
Distribution: Penetration across the blood-brain barrier is poor, despite
inflamed meninges; appears in breast milk
Protein binding: 65%
Metabolism: ~30% of a dose is inactivated in the liver
Time to peak serum concentration: Within 1-4 hours; can persist within the
therapeutic range for 15-24 hours
Elimination: Renal clearance is delayed in neonates, young infants, and
patients with impaired renal function; 60% to 90% of the drug is excreted
unchanged via renal tubular excretion |
|
|
Usual Dosage |
|
I.M.:
Congenital syphilis: 50,000 units/kg/day for 10-14 days
Adults: 0.6-4.8 million units/day in divided doses every 12-24 hours
Endocarditis caused by susceptible viridans Streptococcus (when used
in conjunction with an aminoglycoside): 1.2 million units every 6 hours for 2-4
weeks
Neurosyphilis: I.M.: 2-4 million units/day with 500 mg probenecid by mouth 4
times/day for 10-14 days; penicillin G aqueous I.V. is the preferred
agent
Hemodialysis: Moderately dialyzable (20% to 50%) |
|
|
Administration |
|
Procaine suspension for deep I.M. injection only; rotate the injection site
avoid I.V., intravascular, or intra-arterial administration of penicillin G
procaine since severe and/or permanent neurovascular damage may
occur |
|
|
Monitoring
Parameters |
|
Periodic renal and hematologic function tests with prolonged therapy; fever,
mental status, WBC count |
|
|
Test
Interactions |
|
Positive Coombs' [direct], false-positive urinary and/or serum
proteins |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Take as directed, for full course of therapy. Maintain adequate hydration
(2-3 L/day of fluids unless instructed to restrict fluid intake). If being
treated for sexually transmitted disease, partner will also need to be treated.
Small frequent meals, frequent mouth care, sucking lozenges, or chewing gum may
reduce nausea or dry mouth. Important to maintain good oral and vaginal hygiene
to reduce incidence of opportunistic infection. If diabetic, drug may cause
false tests with Clinitest® urine glucose monitoring; use
of glucose oxidase methods (Clinistix®) or serum glucose
monitoring is preferable. This drug may interfere with oral contraceptives; an
alternate form of birth control should be used. Report persistent diarrhea,
fever, chills, unhealed sores, bloody urine or stool, muscle pain, mouth sores,
or difficulty breathing. |
|
|
Nursing
Implications |
|
Renal and hematologic systems should be evaluated periodically during
prolonged therapy; do not inject in gluteal muscle in children <2 years of
age |
|
|
Dosage Forms |
|
Injection, suspension: 300,000 units/mL (10 mL); 500,000 units/mL (1.2 mL);
600,000 units/mL (1 mL, 2 mL, 4 mL) |
|
|
References |
|
Donowitz GR and Mandell GL, "Beta-Lactam Antibiotics," N Engl J Med,
1988, 318(7):419-26 and 318(8):490-500.
Paryani SG, Vaughn AJ, Crosby M, et al,
"Treatment of Asymptomatic Congenital Syphilis: Benzathine Versus Procaine Penicillin G Therapy,"
J Pediatr, 1994, 125(3):471-5.
Wright AJ, "The Penicillins," Mayo Clin Proc, 1999, 74(3):290-307.
Yoshikawa TT, "Antimicrobial Therapy for the Elderly Patient," J Am
Geriatr Soc, 1990, 38(12):1353-72.
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|